Understand the source comparison
LL-37 vs Other Antimicrobial Peptides: Timeline Comparison
Different antimicrobial peptides exhibit distinct kinetic profiles, and understanding where LL-37 sits within this spectrum helps calibrate timeline expectations. LL-37 (human cathelicidin) Membrane disruption + immune signaling via FPRL1 24–72 hours (biofilm)
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Different antimicrobial peptides exhibit distinct kinetic profiles, and understanding where LL-37 sits within this spectrum helps calibrate timeline expectations.
- LL-37 (human cathelicidin)
- Membrane disruption + immune signaling via FPRL1
- 24–72 hours (biofilm); 6–12 hours (planktonic)
- 12–24 hours (cytokine release)
- Low (serum half-life 30–60 min)
- Dual-phase activity makes it ideal for protocols measuring both rapid immune response and sustained antimicrobial effects, but proteolytic sensitivity requires frequent dosing
- Defensins (HBD-2, HBD-3)
- Membrane pore formation + chemokine activity
- 12–48 hours (concentration-dependent)
- 6–18 hours
- Moderate (disulfide bonds confer stability)
- Faster initial antimicrobial activity than LL-37 but narrower immune-modulating effects; better suited for direct bacterial challenge studies
- Magainin-2 (frog skin peptide)
- Membrane permeabilization via toroidal pore
- 2–6 hours (planktonic); 48–96 hours (biofilm)
- Minimal (limited immunomodulatory activity)
- Moderate
- Rapid bactericidal activity against planktonic cultures but lacks the immune-signaling dimension of LL-37; timeline accelerates in low-salt media
- Polymyxin B
- Lipid A binding and outer membrane disruption
- 1–4 hours (Gram-negative)
- None (not immunomodulatory)
- High (cyclic structure resists proteases)
- Fastest time-to-kill for Gram-negative bacteria but zero immune-modulating function; useful as a comparative control for direct antimicrobial vs immunomodulatory timelines
- Nisin (bacteriocin)
- Lipid II binding and pore formation
- 4–12 hours (Gram-positive)
- None
- High (post-translational modifications)
- Narrow spectrum (Gram-positive only) but extremely stable; timeline unaffected by protease-rich environments where LL-37 degrades
- The comparison reveals that LL-37's timeline is slower than direct membrane-disrupting peptides like polymyxin B or magainin-2 for planktonic bacterial killing, but its dual immune-modulating activity introduces therapeutic dimensions those peptides cannot replicate. For protocols prioritizing wound healing, angiogenesis, or adaptive immune priming, LL-37's 7–14 day timeline to full effect is mechanistically justified. Those processes require sustained cytokine signaling and cellular migration that unfold over days. Researchers selecting peptides for rapid bactericidal screens may find defensins or polymyxins deliver measurable endpoints faster, but those measuring complex host-pathogen interactions will require LL-37's extended timeline to capture the full biological response.